These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33308435)

  • 1. The phases of hepatitis C elimination: achieving WHO elimination targets.
    Pedrana A; Munari S; Stoové M; Doyle J; Hellard M
    Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):6-8. PubMed ID: 33308435
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
    Dore GJ; Hajarizadeh B
    Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global elimination of hepatitis C?
    Sonderup MW
    S Afr Med J; 2018 Aug; 108(8b):31-34. PubMed ID: 30182910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australia needs to increase testing to achieve hepatitis C elimination.
    Scott N; Sacks-Davis R; Wade AJ; Stoove M; Pedrana A; Doyle JS; Thompson AJ; Wilson DP; Hellard ME
    Med J Aust; 2020 May; 212(8):365-370. PubMed ID: 32167586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
    Naggie S; Wyles D
    J Infect Dis; 2020 Nov; 222(Suppl 9):S741-S744. PubMed ID: 33245351
    [No Abstract]   [Full Text] [Related]  

  • 6. Is global elimination of HCV realistic?
    Calvaruso V; Petta S; Craxì A
    Liver Int; 2018 Feb; 38 Suppl 1():40-46. PubMed ID: 29427499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of viral hepatitis: where do we stand in the year 2020?
    Maticic M; Mondelli MU
    Clin Microbiol Infect; 2020 Jul; 26(7):816-817. PubMed ID: 32120039
    [No Abstract]   [Full Text] [Related]  

  • 8. Global elimination of hepatitis C virus by 2030: why not?
    Dore GJ; Martinello M; Alavi M; Grebely J
    Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
    [No Abstract]   [Full Text] [Related]  

  • 9. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Elimination of Hepatitis C as a Public Health Threat.
    Hellard M; Schroeder SE; Pedrana A; Doyle J; Aitken C
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31712223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment access is only the first step to hepatitis C elimination: experience of universal anti-viral treatment access in Australia.
    Doyle JS; Scott N; Sacks-Davis R; Pedrana AE; Thompson AJ; Hellard ME;
    Aliment Pharmacol Ther; 2019 May; 49(9):1223-1229. PubMed ID: 30908706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
    Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
    BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 14. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study.
    Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT;
    J Viral Hepat; 2019 Jan; 26(1):83-92. PubMed ID: 30267593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade.
    Scott N; Doyle JS; Wilson DP; Wade A; Howell J; Pedrana A; Thompson A; Hellard ME
    Int J Drug Policy; 2017 Sep; 47():107-116. PubMed ID: 28797497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
    Mangia A; Albanese AP; Bourliére M; Craxi A; Dieterich D; Solomon S; Vanstraelen K; Hernandez C; Turnes J
    Adv Ther; 2021 Mar; 38(3):1397-1403. PubMed ID: 33590446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis elimination by 2030: Progress and challenges.
    Waheed Y; Siddiq M; Jamil Z; Najmi MH
    World J Gastroenterol; 2018 Nov; 24(44):4959-4961. PubMed ID: 30510370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.